Martin D. Madaus

Chairman

Equibles does not estimate personal net worth.

Get an email with a short summary when Repligen Corp publishes a filing, an earnings call transcript or a press release.

Get RGEN alerts

About Martin D. Madaus

Martin D. Madaus is recorded as Chairman at Repligen Corp (RGEN) since March 13, 2026. Repligen Corp reported in an 8-K filed January 6, 2026 that Martin D. Madaus was appointed Chair of the Board, effective March 13, 2026. Repligen Corp is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Repligen Corp includes Olivier Loeillot (CEO and Board Member), Dr. Martin D. Madaus (Chairman and Board Member), Tony J. Hunt (Chairman) and 7 others.

“On January 6, 2026, Repligen Corporation (the "Company") announced that the Board of Directors (the "Board") has elected Dr. Martin D. Madaus as Chair of the Board, effective March 13, 2026 (the "Effective Date").”

Repligen Corp Form 8-K, filed January 6, 2026 · Read the filing

Affiliation history

Repligen Corp (RGEN)
Chairman

SEC 8-K

Current
2026-03-13–present
Repligen Corp (RGEN)
Board Member

Proxy statement

Start not stated–2023-04-11

Last confirmed by a filing; no departure on record

Company network

Repligen Corp

RGEN

Current role

Medical Instruments & Supplies · Healthcare

Chairman

2026-03-13–present

Leadership on record at Repligen Corp

Olivier Loeillot CEO, Board Member
Dr. Martin D. Madaus Chairman, Board Member
Tony J. Hunt Chairman
Jason Garland CFO
Jason K. Garland CFO, Chief Accounting Officer
James Bylund COO
Violetta Hughes Chief Accounting Officer
Carrie Eglinton Manner Board Member
Glenn P. Muir Board Member
Konstantin Konstantinov Board Member

Recent activity

Executive change Appointed: Chair of the Board Repligen Corp (RGEN)
2026-03-13